Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-02-13 Sale | 2025-02-14 6:20 pm | NEUROCRINE BIOSCIENCES INC | NBIX | Gano Kyle Chief Executive Officer | 2,558 | $116.85 | $298,908 | 276,128 (Direct) | View |
| 2025-02-10 Sale | 2025-02-12 6:48 pm | NEUROCRINE BIOSCIENCES INC | NBIX | Gano Kyle Chief Executive Officer | 980 | $118.39 | $116,020 | 137,658 (Direct) | View |
| 2025-01-31 Sale | 2025-02-04 5:47 pm | NEUROCRINE BIOSCIENCES INC | NBIX | Gano Kyle Chief Executive Officer | 1,541 | $152.87 | $235,577 | 139,705 (Direct) | View |
| 2025-01-15 Sale | 2025-01-17 4:32 pm | NEUROCRINE BIOSCIENCES INC | NBIX | Gano Kyle Chief Executive Officer | 65,000 | $141.5 | $9,197,550 | 135,392 (Direct) | View |
| 2024-02-13 Sale | 2024-02-15 5:40 pm | NEUROCRINE BIOSCIENCES INC | NBIX | Gano Kyle Chief Business Development Off | 1,352 | $132.89 | $179,674 | 189,190 (Direct) | View |
| 2024-02-06 Sale | 2024-02-08 7:17 pm | NEUROCRINE BIOSCIENCES INC | NBIX | Gano Kyle Chief Business Development Off | 2,580 | $139.16 | $359,041 | 133,952 (Direct) | View |
| 2024-01-31 Sale | 2024-02-02 7:17 pm | NEUROCRINE BIOSCIENCES INC | NBIX | Gano Kyle Chief Business Development Off | 1,541 | $140.7 | $216,813 | 131,635 (Direct) | View |
| 2024-01-02 Sale | 2024-01-04 6:32 pm | NEUROCRINE BIOSCIENCES INC | NBIX | Gano Kyle Chief Business Development Off | 75,000 | $131.47 | $9,860,194 | 130,250 (Direct) | View |
| 2023-08-21 Sale | 2023-08-23 8:05 pm | NEUROCRINE BIOSCIENCES INC | NBIX | Gano Kyle Chief Business Development Off | 2,132 | $107.41 | $228,993 | 130,250 (Direct) | View |
| 2023-02-06 Sale | 2023-02-08 7:25 pm | NEUROCRINE BIOSCIENCES INC | NBIX | Gano Kyle Chief Business Development Off | 17,004 | $102.79 | $1,747,920 | 128,096 (Direct) | View |
| 2023-01-31 Sale | 2023-02-02 5:15 pm | NEUROCRINE BIOSCIENCES INC | NBIX | Gano Kyle Chief Business Development Off | 1,541 | $109.98 | $169,486 | 112,820 (Direct) | View |
| 2022-02-07 Sale | 2022-02-09 6:58 pm | NEUROCRINE BIOSCIENCES INC | NBIX | Gano Kyle Chief Business Development Off | 6,880 | $80.61 | $554,628 | 111,173 (Direct) | View |
| 2022-01-05 Sale | 2022-01-07 6:04 pm | NEUROCRINE BIOSCIENCES INC | NBIX | Gano Kyle Chief Business Development Off | 28,266 | $85.5 | $2,416,751 | 104,984 (Direct) | View |
| 2021-02-05 Sale | 2021-02-09 9:42 pm | NEUROCRINE BIOSCIENCES INC | NBIX | Gano Kyle Chief Business Development Off | 6,370 | $115.65 | $736,702 | 156,839 (Direct) | View |
| 2020-11-12 Sale | 2020-11-16 6:11 pm | NEUROCRINE BIOSCIENCES INC | NBIX | Gano Kyle Chief Business Development Off | 2,257 | $90.73 | $204,770 | 98,028 (Direct) | View |
| 2020-08-05 Sale | 2020-08-07 7:24 pm | NEUROCRINE BIOSCIENCES INC | NBIX | Gano Kyle Chief Business Development Off | 2,257 | $118.87 | $268,286 | 95,997 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-02-12 Option Award | 2025-02-14 6:20 pm | N/A 2035-02-12 | NEUROCRINE BIOSCIENCES INC | NBIX | Gano Kyle Chief Executive Officer | 124,364 | $0 | 276,128 (Direct) | View |
| 2025-02-13 Exercise | 2025-02-14 6:20 pm | N/A N/A | NEUROCRINE BIOSCIENCES INC | NBIX | Gano Kyle Chief Executive Officer | 4,807 | $0 | 276,128 (Direct) | View |
| 2025-02-08 Exercise | 2025-02-12 6:48 pm | N/A N/A | NEUROCRINE BIOSCIENCES INC | NBIX | Gano Kyle Chief Executive Officer | 1,860 | $0 | 137,658 (Direct) | View |
| 2025-01-31 Exercise | 2025-02-04 5:47 pm | N/A N/A | NEUROCRINE BIOSCIENCES INC | NBIX | Gano Kyle Chief Executive Officer | 2,927 | $0 | 139,705 (Direct) | View |
| 2025-01-15 Exercise | 2025-01-17 4:32 pm | N/A 2025-02-03 | NEUROCRINE BIOSCIENCES INC | NBIX | Gano Kyle Chief Executive Officer | 65,000 | $0 | 135,392 (Direct) | View |
| 2025-01-15 Exercise | 2025-01-17 4:32 pm | N/A N/A | NEUROCRINE BIOSCIENCES INC | NBIX | Gano Kyle Chief Executive Officer | 65,000 | $32.99 | 135,392 (Direct) | View |
| 2024-11-01 Option Award | 2024-11-01 7:52 pm | N/A N/A | NEUROCRINE BIOSCIENCES INC | NBIX | Gano Kyle Chief Executive Officer | 15,799 | $0 | 15,799 (Direct) | View |
| 2024-02-13 Option Award | 2024-02-15 5:40 pm | N/A 2034-02-13 | NEUROCRINE BIOSCIENCES INC | NBIX | Gano Kyle Chief Business Development Off | 54,024 | $0 | 189,190 (Direct) | View |
| 2024-01-02 Exercise | 2024-01-04 6:32 pm | N/A 2024-01-16 | NEUROCRINE BIOSCIENCES INC | NBIX | Gano Kyle Chief Business Development Off | 75,000 | $19.59 | 130,250 (Direct) | View |
| 2023-02-13 Option Award | 2023-02-15 7:10 pm | N/A 2033-02-13 | NEUROCRINE BIOSCIENCES INC | NBIX | Gano Kyle Chief Business Development Off | 74,053 | $0 | 74,053 (Direct) | View |
| 2022-01-31 Option Award | 2022-02-02 8:02 pm | N/A 2032-01-31 | NEUROCRINE BIOSCIENCES INC | NBIX | Gano Kyle Chief Business Development Off | 91,426 | $0 | 91,426 (Direct) | View |
| 2022-01-05 Exercise | 2022-01-07 6:04 pm | N/A 2022-01-12 | NEUROCRINE BIOSCIENCES INC | NBIX | Gano Kyle Chief Business Development Off | 28,266 | $8.66 | 104,984 (Direct) | View |
| 2021-02-08 Option Award(A) | 2021-03-29 06:15 am | N/A 2031-02-08 | NEUROCRINE BIOSCIENCES INC | NBIX | Gano Kyle Chief Business Development Off | 49,049 | $0 | 49,049 (Direct) | View |
| 2021-02-08 Option Award | 2021-02-09 9:42 pm | N/A 2031-02-08 | NEUROCRINE BIOSCIENCES INC | NBIX | Gano Kyle Chief Business Development Off | 52,071 | $0 | 156,839 (Direct) | View |